Oates JA - Search Results

1

Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.

Roden DM, Reele SB, Higgins SB, Wilkinson GR, Smith RF, Oates JA, Woosley RL. Roden DM, et al. Among authors: oates ja. Am J Cardiol. 1980 Sep;46(3):463-8. doi: 10.1016/0002-9149(80)90016-8. Am J Cardiol. 1980. PMID: 6158263 Clinical Trial.

2

Electrophysiologic actions of high plasma concentrations of propranolol in human subjects.

Duff HJ, Roden DM, Brorson L, Wood AJ, Dawson AK, Primm RK, Oates JA, Smith RF, Woosley RL. Duff HJ, et al. Among authors: oates ja. J Am Coll Cardiol. 1983 Dec;2(6):1134-40. doi: 10.1016/s0735-1097(83)80340-4. J Am Coll Cardiol. 1983. PMID: 6630784 Free article.

3

Suppression of chronic ventricular arrhythmias with propranolol.

Woosley RL, Kornhauser D, Smith R, Reele S, Higgins SB, Nies AS, Shand DG, Oates JA. Woosley RL, et al. Among authors: oates ja. Circulation. 1979 Oct;60(4):819-27. doi: 10.1161/01.cir.60.4.819. Circulation. 1979. PMID: 476887

4

Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2',6'-propionoxylidide, in man.

McDevitt DG, Nies AS, Wilkinson GR, Smith RF, Woosley RL, Oates JA. McDevitt DG, et al. Among authors: oates ja. Clin Pharmacol Ther. 1976 Apr;19(4):396-402. doi: 10.1002/cpt1976194396. Clin Pharmacol Ther. 1976. PMID: 773580 Clinical Trial.

5

Suppression of ventricular ectopic depolarizations by tocainide.

Woosley RL, McDevitt DG, Nies AS, Smith RF, Wilkinson GR, Oates JA. Woosley RL, et al. Among authors: oates ja. Circulation. 1977 Dec;56(6):980-4. doi: 10.1161/01.cir.56.6.980. Circulation. 1977. PMID: 923067 Clinical Trial.

6

Simultaneous quantification of procainamide and N-acetylprocainamide with high-performance liquid chromatography.

Carr K, Woosley RL, Oates JA. Carr K, et al. Among authors: oates ja. J Chromatogr. 1976 Dec 22;129:363-8. doi: 10.1016/s0021-9673(00)87796-1. J Chromatogr. 1976. PMID: 1002795

7

Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmias.

Duff HJ, Roden DM, Yacobi A, Robertson D, Wang T, Maffucci RJ, Oates JA, Woosley RL. Duff HJ, et al. Among authors: oates ja. Am J Cardiol. 1985 Feb 1;55(4):395-401. doi: 10.1016/0002-9149(85)90383-2. Am J Cardiol. 1985. PMID: 3969876 Clinical Trial.

8

Metabolism of procainamide in the perfused rat liver.

Uetrecht JP, Woosley RL, Freeman RW, Sweetman BJ, Oates JA. Uetrecht JP, et al. Among authors: oates ja. Drug Metab Dispos. 1981 May-Jun;9(3):183-7. Drug Metab Dispos. 1981. PMID: 6166441

9

Selection of an antiarrhythmic drug for a sudden-death-prevention trial.

Woosley RL, Roden DM, Duff HJ, Oates JA. Woosley RL, et al. Among authors: oates ja. Am Heart J. 1982 Apr;103(4 Pt 2):737-45. doi: 10.1016/0002-8703(82)90481-1. Am Heart J. 1982. PMID: 6175198 Clinical Trial.

10

The antiarrhythmic activity of meobentine sulfate in man.

Duff HJ, Oates JA, Roden DM, Woosley RL. Duff HJ, et al. Among authors: oates ja. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):650-6. doi: 10.1097/00005344-198407000-00015. J Cardiovasc Pharmacol. 1984. PMID: 6206320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

414 results

Search Page